Table 4.
Questions to address | Process |
---|---|
What proportion of the total health care budget can a country spend on ESKD care relative to the desired level of health status, available technology, and costs without enhancing inequity? | Health science evaluation |
What is the economic and societal return of money invested in KRT care by way of promoting local manufacturing and creating jobs, skills, trade, and knowledge? | Societal and economic evaluation |
What is the best way of comparing HD and PD in terms of their impact on equity of care provision and how can this be implemented? | Health technology assessment |
What are the minimal essential requirements to safely implement a transplantation program in an equitable way in LMICs? | Scientific medical evaluation, systematic review, Delphi |
Which models are in use for implementation of ESKD care in LMICs; what were the results; which factors (modifiable and nonmodifiable) determined success or failure and their impact on equity? (Consider governmental vs. external programs, public vs. private, prevention vs. curing, mixed models.) | Systematic review, epidemiology, health care sciences |
Is there inequity in access to provided care and outcome based on sex? | Systematic review; epidemiology |
ESKD, end-stage kidney disease; HD, hemodialysis; KRT, kidney replacement therapy; LMICs, low- and middle-income countries; PD, peritoneal dialysis.